Cheng Du Sheng Nuo Biotec Hits Day Low Amid Price Pressure at CNY 24.80

Cheng Du Sheng Nuo Biotec Co., a midcap player in the Pharmaceuticals & Biotechnology sector, experienced significant volatility on July 17, 2026, with its stock price declining by 14.29%. The stock reached an intraday low of CNY 24.80, reflecting a challenging trading day compared to the broader market, as the China Shanghai Composite index fell by 3.05% during the same period. Over the past week, Cheng Du Sheng Nuo Biotec has seen a decrease of 14.76%, while its performance over the past month remains positive at 7.7%. However, the stock's year-to-date performance shows a decline of 7.75%. In the longer term, the company has demonstrated resilience with a three-year performance increase of 74.11% and a five-year increase of 59.83%, significantly outperforming the China Shanghai Composite. Financial metrics indicate a return on equity of 15.73% and a price-to-earnings ratio of 28.00, suggesting a fair valuation in the current market environment. The company's market capitalization stands at CNY 4,870 million, positioning it as a notable entity within its industry.